Fluorimetric determination of tauromustine (a novel antitumour agent) in formulations and biological fluids.
Walash
M I
MI
Department of Analytical Chemistry, Faculty of Pharmacy, University of Mansoura, Egypt.
Belal
F
F
Metwally
M E
ME
Hefnawy
M M
MM
D000970:Antineoplastic Agents / Q000032:analysis* / Q000097:blood / Q000652:urine; D002138:Calibration; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D009607:Nitrosourea Compounds / Q000032:analysis* / Q000097:blood / Q000652:urine; D012044:Regression Analysis; D012680:Sensitivity and Specificity; D013050:Spectrometry, Fluorescence; D013607:Tablets / Q000032:analysis; D013654:Taurine / Q000031:analogs & derivatives* / Q000032:analysis / Q000097:blood / Q000652:urine
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D013607:Tablets; D013654:Taurine; C052991:1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea